2021
DOI: 10.1097/apo.0000000000000403
|View full text |Cite
|
Sign up to set email alerts
|

Economic Evaluations of Artificial Intelligence in Ophthalmology

Abstract: Artificial intelligence (AI) is expected to cause significant medical quality enhancements and cost-saving improvements in ophthalmology. Although there has been a rapid growth of studies on AI in the recent years, real-world adoption of AI is still rare. One reason may be because the data derived from economic evaluations of AI in health care, which policy makers used for adopting new technology, have been fragmented and scarce. Most data on economics of AI in ophthalmology are from diabetic retinopathy (DR) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
22
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 50 publications
(99 reference statements)
1
22
0
1
Order By: Relevance
“…Cost is an important issue in the adoption of AI-assisted eye disease diagnosis technology. Therefore, it is necessary to conduct health economics evaluation [ 36 ]. Fortunately, evidence has shown the cost of screening could be saved by using AI technology, which is mainly attributable to the substantial reduction in human assessment time and workforce without sacrificing screening performance [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…Cost is an important issue in the adoption of AI-assisted eye disease diagnosis technology. Therefore, it is necessary to conduct health economics evaluation [ 36 ]. Fortunately, evidence has shown the cost of screening could be saved by using AI technology, which is mainly attributable to the substantial reduction in human assessment time and workforce without sacrificing screening performance [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…Images obtained can be graded remotely by trained graders or using smartphone-based automated analysis software [ 20 ]. Recent evidence from cost-effectiveness analysis shows that AI, either standalone or used with humans, might be more cost-effective than manual DR screening [ 21 ]. Unfortunately, efforts to improve screening programs faced with the lack of treatments such as photocoagulation and intravitreal injections of vascular endothelial growth factor (VEGF) that are unavailable in many parts of Africa.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, it should be noted that for a proper assessment, correct segmentation is necessary, and often there is improvement in NVC recognition with manual segmentation [79,81,86,93,103,104]. In the future, the accuracy of NVC detection in vitreoretinal slabs might increase with improvement of auto segmentation, deep learning and artificial intelligence [81,86,[107][108][109][110][111]. IRMAs seem to generate higher false positive rates due to the retinal slab image, despite the vitreoretinal slab image not showing extension into the vitreous cavity [82].…”
Section: Discussionmentioning
confidence: 99%